Skip to main content
OpenTrials
Completed

NCT Number: NCT04422002

Survival Analysis of Frail Patients With Localised Colorectal Cancer

The purpose of this study is to analyse the survival of frail patients with localized colorectal cancer who undergo surgical treatment in comparison with those with palliative treatment

Completed

Looking for future studies?

Notify Me

Key information

About this study

Patients with localized colorectal cancer will be visited by a colorectal surgeon who will explain the disease and the surgical treatment. In this visit the patient will be screened for frailty and asked for informed consent. Patients who meet the eligibility criteria will be sent to the internal medicine consultant to frailty evaluation, risk assessment and counselling in order to help patient decision process.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Localised colorectal cancer
  • Positive frailty screening

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Survival

    Time frame: 1 year

Secondary outcomes

  1. Surgical complications

    Time frame: 30 days

Sponsors and collaborators

Lead sponsor

Corporacion Parc Tauli

Other

Registry information

Official study title

Survival Analysis of Frail Patients With Localised Colorectal Cancer: Multicentre Observational Study, Comparing Surgical vs Palliative Treatment

Important dates

Study start
2019
Primary completion
2023
Study completion
2023
First posted
Jun 9, 2020
Registry last updated
Feb 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.